229 related articles for article (PubMed ID: 22101790)
1. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
Dastpeyman M; Motamed N; Azadmanesh K; Mostafavi E; Kia V; Jahanian-Najafabadi A; Shokrgozar MA
Med Oncol; 2012 Dec; 29(4):2512-8. PubMed ID: 22101790
[TBL] [Abstract][Full Text] [Related]
2. Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line.
Lashgarian HE; Adamii V; Ghorbanzadeh V; Chodari L; Kamali F; Akbari S; Dariushnejad H
Drug Res (Stuttg); 2020 Oct; 70(10):478-483. PubMed ID: 32791535
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.
Meenakshi Sundaram DN; Kucharski C; Parmar MB; Kc RB; Uludağ H
Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
5. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
[TBL] [Abstract][Full Text] [Related]
6. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.
Mokhtari MJ; Motamed N; Shokrgozar MA
Cell Biol Int; 2008 Aug; 32(8):888-92. PubMed ID: 18538589
[TBL] [Abstract][Full Text] [Related]
8. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
Zhang Y; Gong Y; Hu D; Zhu P; Wang N; Zhang Q; Wang M; Aldeewan A; Xia H; Qu X; Ring BZ; Minato N; Su L
Oncogene; 2015 Mar; 34(11):1451-62. PubMed ID: 24704834
[TBL] [Abstract][Full Text] [Related]
9. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
Zhang Y; Rivera Rosado LA; Moon SY; Zhang B
J Biol Chem; 2009 May; 284(19):12956-65. PubMed ID: 19269969
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
[TBL] [Abstract][Full Text] [Related]
11. Adhesion and migration of extracellular matrix-stimulated breast cancer.
Bartsch JE; Staren ED; Appert HE
J Surg Res; 2003 Mar; 110(1):287-94. PubMed ID: 12697413
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Vashum Y; Premsingh R; Kottaiswamy A; Soma M; Padmanaban A; Kalaiselvan P; Samuel S
Mol Biol Rep; 2021 Jan; 48(1):105-116. PubMed ID: 33294960
[TBL] [Abstract][Full Text] [Related]
13. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
Chen IH; Chang FR; Wu YC; Kung PH; Wu CC
Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085
[TBL] [Abstract][Full Text] [Related]
14. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
[TBL] [Abstract][Full Text] [Related]
16. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.
Momeny M; Ghasemi R; Valenti G; Miranda M; Zekri A; Zarrinrad G; Javadikooshesh S; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Tumour Biol; 2016 Mar; 37(3):3913-23. PubMed ID: 26482609
[TBL] [Abstract][Full Text] [Related]
17. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
Si L; Fu J; Liu W; Hayashi T; Nie Y; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Mol Cell Biochem; 2020 Jan; 463(1-2):189-201. PubMed ID: 31612353
[TBL] [Abstract][Full Text] [Related]
18. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
Bayram D; Çetin ES; Kara M; Özgöçmen M; Candan IA
Hum Exp Toxicol; 2017 Jun; 36(6):573-586. PubMed ID: 27402681
[TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]